| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota and 2 University of Minnesota Cancer Center, Minneapolis, Minnesota; 3 Ohio State University, Columbus, Ohio; 4 Children's Hospital at the Cleveland Clinic, Cleveland, Ohio; 5 Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; 6 Children's Hospital Medical Center, Cincinnati, Ohio; 7 Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota; 8 Fred Hutchinson Cancer Research Center, Seattle, Washington; and 9 Children's National Medical Center, Washington, District of Columbia
Requests for reprints: Logan G. Spector, Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, 420 Delaware Street, SE MMC 715, Minneapolis, MN 55455. Phone: 612-624-3912; Fax: 612-624-7147. E-mail: spector{at}epi.umn.edu
Background: The MLL 11q23 translocation arises in utero and is present in 75% of infant leukemias. That MLL+ acute myeloid leukemia (AML) can arise following chemotherapy with DNA topoisomerase II (DNAt2) inhibitors suggests that these substances, which also occur naturally in foods, may contribute toward infant leukemia. We hypothesized that maternal consumption of dietary DNAt2 inhibitors during pregnancy would increase the risk of infant leukemia, particularly AML(MLL+).
Methods: This Children's Oncology Group case-control study consisted of 240 incident cases of infant acute leukemia [AML and acute lymphoblastic leukemia (ALL)] diagnosed during 1996 to 2002 and 255 random digit dialed controls. Maternal diet during pregnancy was determined through a food frequency questionnaire. An index of specific foods identified a priori to contain DNAt2 inhibitors as well as vegetables and fruits were created and analyzed using unconditional logistic regression.
Results: There was little evidence of an association between the specific DNAt2 index and leukemia overall and by subtype. An exception was AML(MLL+); odds ratios (95% confidence intervals) comparing the second to fourth quartiles to the first were 1.9 (0.5-7.0), 2.1 (0.6-7.7), and 3.2 (0.9-11.9), respectively (P for trend = 0.10). For the vegetable and fruit index, there were significant or near-significant inverse linear trends for all leukemias combined, ALL(MLL+), and AML(MLL–).
Conclusion: Overall, maternal consumption of fresh vegetables and fruits during pregnancy was associated with a decreased risk of infant leukemia, particularly MLL+. However, for AML(MLL+) cases, maternal consumption of specific DNAt2 inhibitors seemed to increase risk. Although based on small numbers, these data provide some support for distinct etiologic pathways in infant leukemia.
This article has been cited by other articles:
|
|
 |
|
  S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten Dietary flavonoids induce MLL translocations in primary human CD34+ cells Carcinogenesis, August 1, 2007; 28(8): 1703 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Bunin, L. G. Spector, A. F. Olshan, L. L. Robison, M. Roesler, S. Grufferman, X.-o. Shu, and J. A. Ross Secular Trends in Response Rates for Controls Selected by Random Digit Dialing in Childhood Cancer Studies: A Report from the Children's Oncology Group Am. J. Epidemiol., July 1, 2007; 166(1): 109 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Spector, S. M. Davies, L. L. Robison, J. M. Hilden, M. Roesler, and J. A. Ross Birth Characteristics, Maternal Reproductive History, and the Risk of Infant Leukemia: A Report from the Children's Oncology Group Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Spector and J. A. Ross Infant Leukemia: Finding the Needle in the Haystack Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2331 - 2331. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Pombo-de-Oliveira, S. Koifman, and Brazilian Collaborative Study Group of Infant Acut Infant Acute Leukemia and Maternal Exposures during Pregnancy Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2336 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Aldrich, L. Zhang, J. L. Wiemels, X. Ma, M. L. Loh, C. Metayer, S. Selvin, J. Feusner, M. T. Smith, and P. A. Buffler Cytogenetics of Hispanic and white children with acute lymphoblastic leukemia in california. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 578 - 581. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
